Home > Publications Database > Mega-analysis methods in ENIGMA: The experience of the generalized anxiety disorder working group. > print

001     154390
005     20240318115418.0
024 7 _ |a pmc:PMC8675407
|2 pmc
024 7 _ |a 10.1002/hbm.25096
|2 doi
024 7 _ |a pmid:32596977
|2 pmid
024 7 _ |a 1065-9471
|2 ISSN
024 7 _ |a 1097-0193
|2 ISSN
024 7 _ |a altmetric:84916467
|2 altmetric
037 _ _ |a DZNE-2021-00243
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zugman, André
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Mega-analysis methods in ENIGMA: The experience of the generalized anxiety disorder working group.
260 _ _ |a New York, NY
|c 2022
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710757510_18973
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ISSN 1097-0193 not unique: **3 hits**.
520 _ _ |a The ENIGMA group on Generalized Anxiety Disorder (ENIGMA-Anxiety/GAD) is part of a broader effort to investigate anxiety disorders using imaging and genetic data across multiple sites worldwide. The group is actively conducting a mega-analysis of a large number of brain structural scans. In this process, the group was confronted with many methodological challenges related to study planning and implementation, between-country transfer of subject-level data, quality control of a considerable amount of imaging data, and choices related to statistical methods and efficient use of resources. This report summarizes the background information and rationale for the various methodological decisions, as well as the approach taken to implement them. The goal is to document the approach and help guide other research groups working with large brain imaging data sets as they develop their own analytic pipelines for mega-analyses.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a data sharing
|2 Other
650 _ 7 |a generalized anxiety disorder
|2 Other
650 _ 7 |a mega-analyses
|2 Other
650 _ 7 |a meta-analyses
|2 Other
650 _ 7 |a neuroimaging
|2 Other
650 _ 2 |a Anxiety Disorders: diagnostic imaging
|2 MeSH
650 _ 2 |a Cerebral Cortex: diagnostic imaging
|2 MeSH
650 _ 2 |a Data Interpretation, Statistical
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Meta-Analysis as Topic
|2 MeSH
650 _ 2 |a Multicenter Studies as Topic: methods
|2 MeSH
650 _ 2 |a Multicenter Studies as Topic: standards
|2 MeSH
650 _ 2 |a Neuroimaging: methods
|2 MeSH
650 _ 2 |a Neuroimaging: standards
|2 MeSH
700 1 _ |a Harrewijn, Anita
|b 1
700 1 _ |a Cardinale, Elise M
|b 2
700 1 _ |a Zwiebel, Hannah
|b 3
700 1 _ |a Freitag, Gabrielle F
|b 4
700 1 _ |a Werwath, Katy E
|b 5
700 1 _ |a Bas-Hoogendam, Janna M
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Groenewold, Nynke A
|b 7
700 1 _ |a Aghajani, Moji
|b 8
700 1 _ |a Hilbert, Kevin
|b 9
700 1 _ |a Cardoner, Narcis
|b 10
700 1 _ |a Porta-Casteràs, Daniel
|b 11
700 1 _ |a Gosnell, Savannah
|b 12
700 1 _ |a Salas, Ramiro
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Blair, Karina S
|b 14
700 1 _ |a Blair, James R
|b 15
700 1 _ |a Hammoud, Mira Z
|b 16
700 1 _ |a Milad, Mohammed
|b 17
700 1 _ |a Burkhouse, Katie
|b 18
700 1 _ |a Phan, K Luan
|b 19
700 1 _ |a Schroeder, Heidi K
|b 20
700 1 _ |a Strawn, Jeffrey R
|b 21
700 1 _ |a Beesdo-Baum, Katja
|b 22
700 1 _ |a Thomopoulos, Sophia I
|b 23
700 1 _ |a Grabe, Hans J
|0 P:(DE-2719)2811781
|b 24
|u dzne
700 1 _ |a Van der Auwera, Sandra
|0 P:(DE-2719)9001174
|b 25
|u dzne
700 1 _ |a Wittfeld, Katharina
|0 P:(DE-2719)2810491
|b 26
|u dzne
700 1 _ |a Nielsen, Jared A
|b 27
700 1 _ |a Buckner, Randy
|b 28
700 1 _ |a Smoller, Jordan W
|b 29
700 1 _ |a Mwangi, Benson
|b 30
700 1 _ |a Soares, Jair C
|b 31
700 1 _ |a Wu, Mon-Ju
|b 32
700 1 _ |a Zunta-Soares, Giovana B
|b 33
700 1 _ |a Jackowski, Andrea P
|b 34
700 1 _ |a Pan, Pedro M
|b 35
700 1 _ |a Salum, Giovanni A
|b 36
700 1 _ |a Assaf, Michal
|b 37
700 1 _ |a Diefenbach, Gretchen J
|b 38
700 1 _ |a Brambilla, Paolo
|b 39
700 1 _ |a Maggioni, Eleonora
|b 40
700 1 _ |a Hofmann, David
|0 P:(DE-HGF)0
|b 41
700 1 _ |a Straube, Thomas
|b 42
700 1 _ |a Andreescu, Carmen
|0 P:(DE-HGF)0
|b 43
700 1 _ |a Berta, Rachel
|b 44
700 1 _ |a Tamburo, Erica
|b 45
700 1 _ |a Price, Rebecca
|b 46
700 1 _ |a Manfro, Gisele G
|b 47
700 1 _ |a Critchley, Hugo D
|b 48
700 1 _ |a Makovac, Elena
|0 P:(DE-HGF)0
|b 49
700 1 _ |a Mancini, Matteo
|b 50
700 1 _ |a Meeten, Frances
|b 51
700 1 _ |a Ottaviani, Cristina
|b 52
700 1 _ |a Agosta, Federica
|b 53
700 1 _ |a Canu, Elisa
|b 54
700 1 _ |a Cividini, Camilla
|b 55
700 1 _ |a Filippi, Massimo
|0 P:(DE-HGF)0
|b 56
700 1 _ |a Kostić, Milutin
|b 57
700 1 _ |a Munjiza, Ana
|b 58
700 1 _ |a Filippi, Courtney A
|b 59
700 1 _ |a Leibenluft, Ellen
|b 60
700 1 _ |a Alberton, Bianca A V
|b 61
700 1 _ |a Balderston, Nicholas L
|b 62
700 1 _ |a Ernst, Monique
|b 63
700 1 _ |a Grillon, Christian
|b 64
700 1 _ |a Mujica-Parodi, Lilianne R
|b 65
700 1 _ |a van Nieuwenhuizen, Helena
|b 66
700 1 _ |a Fonzo, Gregory A
|b 67
700 1 _ |a Paulus, Martin P
|b 68
700 1 _ |a Stein, Murray B
|b 69
700 1 _ |a Gur, Raquel E
|b 70
700 1 _ |a Gur, Ruben C
|b 71
700 1 _ |a Kaczkurkin, Antonia N
|b 72
700 1 _ |a Larsen, Bart
|b 73
700 1 _ |a Satterthwaite, Theodore D
|b 74
700 1 _ |a Harper, Jennifer
|b 75
700 1 _ |a Myers, Michael
|b 76
700 1 _ |a Perino, Michael T
|b 77
700 1 _ |a Yu, Qiongru
|b 78
700 1 _ |a Sylvester, Chad M
|b 79
700 1 _ |a Veltman, Dick J
|b 80
700 1 _ |a Lueken, Ulrike
|b 81
700 1 _ |a Van der Wee, Nic J A
|b 82
700 1 _ |a Stein, Dan J
|b 83
700 1 _ |a Jahanshad, Neda
|b 84
700 1 _ |a Thompson, Paul M
|b 85
700 1 _ |a Pine, Daniel S
|b 86
700 1 _ |a Winkler, Anderson M
|0 P:(DE-HGF)0
|b 87
773 _ _ |a 10.1002/hbm.25096
|g p. hbm.25096
|0 PERI:(DE-600)1492703-2
|n 1
|p 255-277
|t Human brain mapping
|v 43
|y 2022
|x 1097-0193
856 4 _ |u https://pub.dzne.de/record/154390/files/DZNE-2021-00243.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/154390/files/DZNE-2021-00243.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:154390
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 24
|6 P:(DE-2719)2811781
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 25
|6 P:(DE-2719)9001174
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2810491
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 2 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY 3.0
|0 LIC:(DE-HGF)CCBY3
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-01-27
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-09-27T20:46:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-09-27T20:46:01Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2022-09-27T20:46:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HUM BRAIN MAPP : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HUM BRAIN MAPP : 2021
|d 2022-11-22
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of Dementia in the General Population
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000001
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21